ImmProNano

Impronoano (IPN), headquartered in Pennsylvania, is a specialized contract research organization in the fields of human leukocyte antigen T-cell immunology and immuno-proteomics. It utilizes state-of-the-art mass spectrometry technology to determine the Class I major histocompatibility complex expression libraries of virus-infected cells. These libraries are crucial for the development of vaccines against highly pathogenic viruses and intracellular bacterial vaccines. IPN also possesses unparalleled expertise in T-cell immunology of infectious diseases and the development of T-cell vaccines.